Pacira Pharmaceuticals buy HC Wainwright
Start price
04.03.24
/
50%
€26.20
Target price
04.03.25
€52.53
Performance (%)
-9.92%
Price
25.04.24
€23.60
Summary
This prediction is currently active. With a performance of -9.92%, the BUY prediction for Pacira Pharmaceuticals by HC_Wainwright is down slightly. This prediction currently runs until 04.03.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacira Pharmaceuticals | -2.479% | -2.479% |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
Comments by HC_Wainwright for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by HC_Wainwright for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
06.11.23
06.11.23
€53.07
06.11.24
06.11.24
-12.68%
25.04.24
25.04.24